Specialty Interests
cause of neurological disability in multiple sclerosis and stem cell repair of the central nervous system, cellular and molecular biology of myelination
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 9/8/2008, Dr.
Trapp has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Trapp receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
Cognosci, Inc.
Teva Neurosciences, Inc.
Royalty Payments. Dr. Trapp has the right to receive royalty payments for inventions or discoveries related to the companies shown below:
Vertex Pharmaceuticals Incorporated
